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Abstract This report presents a 27-year-old male profes-
sional soccer player who developed heterotopic ossification of
his hip capsule and gluteus minimus tendon after an arthro-
scopic hip procedure. After removal of the heterotopic bone,
the patient had a symptomatic deficiency of his hip capsule
and gluteus minimus tendon. A series of orthobiologic treat-
ments with platelet-rich plasma and bone marrow aspirate
concentrate improved the patient’s pain and strength as well as
the morphologic appearance of the hip capsule and gluteus
minimus tendon on magnetic resonance imaging. A series of
motion analyses demonstrated significant improvement in his
stance-leg ground reaction force and hip abduction, as well as
linear foot velocity at ball strike and maximum hip flexion
following ball strike in his kicking leg.
Level of evidence IV.
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Introduction
The hip capsule is a fibrous and highly vascular soft tissue
stabilizer of the joint [2]. Injury to the capsule occurs
infrequently but may be associated with traumatic dislo-
cations of the hip in addition to iatrogenic injury during hip
arthroscopy or total hip arthroplasty [11, 15, 20, 23].
Capsular deficiency may result in hip instability and/or
pain. Classically, hip capsule tears are treated with surgical
repair; however, there may be a role for less invasive
therapies in select patients with certain occult hip capsular
injuries. Recently, orthobiologics have shown promise in
the treatment of musculoskeletal soft tissue injuries and
may have the potential to treat soft tissue injuries around
the hip [14, 18, 22, 24, 25, 27, 28]. Bone marrow aspiration
concentrate (BMAC) and platelet-rich plasma (PRP) are
two such therapies.
Bone marrow aspirate concentrate contains mesenchy-
mal stem cells which have anti-inflammatory, anti-apop-
totic and multipotent capabilities [6, 21]. They have the
potential to differentiate into several cell lineages including
tenocytes and chondrocytes in the appropriate hematopoi-
etic-inducing microenvironment [6, 7, 19, 32]. Platelet-rich
plasma contains a high concentration of platelets, growth
factors and cytokines necessary for cell differentiation and
tissue healing [9, 29]. Independent use of these biologic
therapies has been reported to result in improvement in the
mechanical properties and histologic appearance of some
musculoskeletal tissues [1, 4, 5, 8, 14, 16, 25–28].
Case report
A 27-year-old male professional soccer player with a
preference for kicking with his left leg developed hetero-
topic ossification of his right hip capsule and gluteus
minimus tendon after an arthroscopic hip procedure. The
heterotopic ossification was active on a bone scan and
classified as Brooker stage II. Subsequently, the patient
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underwent a combination of arthroscopic and open exci-
sion of the heterotopic ossification, a lysis of adhesions and
capsular closure of the right hip. The heterotopic ossifica-
tion was located in the anterior and anterolateral hip cap-
sule and the gluteus minimus tendon (Fig. 1). He was
placed on 6 weeks of indomethacin post-operatively for
heterotopic ossification prophylaxis.
The patient was progressing well with his rehabilitation
until 3 months after his procedure when he developed
recurrent right hip pain after a cross kick during a scrim-
mage. A motion analysis evaluation was undertaken to
analyse the mechanics of his limb during a kicking motion
which demonstrated the apprehension of weight acceptance
of the involved limb and significantly decreased the kick-
ing performance. An MRI demonstrated a tear of the glu-
teus minimus tendon and a defect in the anterolateral hip
capsule. It was believed that a revision arthroscopy may
not be beneficial for the patient to treat his gluteus minimus
tendon and capsular deficiencies, especially in the setting
of his history of heterotopic ossification, and the patient
elected to proceed with biologic injection therapy to aid in
the potential healing of his tendon and capsule tears.
In the operative suite, he underwent an examination
under anaesthesia, which demonstrated no evidence of
macroinstability of the hip. An ultrasound revealed a 3 cm
defect in the capsule immediately lateral to the iliofemoral
ligament and fluid in the gluteus minimus tendon consistent
with tearing. Over the next 16 weeks, he received 3 total
PRP and 2 total BMAC injections. Platelet-rich plasma
injections were of 10 cc and injected under ultrasound
guidance. A total of 60 cc of bone marrow aspirate was
obtained by using the OnControl Automated Bone Marrow
Harvest System (Vidacare, San Antonio, TX) from the left
posterior superior iliac spine region and was prepared and
concentrated to 6 cc. The bone marrow aspirate was also
injected under ultrasound guidance. Post-injection, he was
limited in hyperextension and external rotation to allow his
capsule to heal.
His therapy post-injection was gradually increased to
include global hip strengthening. Eight weeks after the final
injection, he reported no pain. He was able to kick pain free
with either leg. On examination, his right hip range of
motion was symmetric to his contralateral hip and pain
free. He had grade 5/5 strength throughout all major
muscle groups with the exception of internal rotation which
was grade 4/5. Radiographs demonstrated a well-preserved
joint space with a normal femoral head/neck offset, no
evidence of pincer impingement and a minor area of
mature heterotopic ossification. A repeat MRI showed
improvement in the appearance of the capsule and gluteus
minimus tendon with increased scarring and fibrosis in the
previous defect. The labrum was healed at the site of the
repair. He was cleared to return to sport 8 weeks following
his final injection and returned to full activities with his
team.
Performance analysis
A 10-camera infra-red motion capture system (Eagle,
Motion Analysis Corp, Santa Clara, CA) with two force
plates (Bertec Corporation, Columbus, OH) and using 54
reflective markers recorded the patient completing a cross
soccer pass with his preferred leg which was the motion
that caused the capsular injury. Multiple trials were
recorded at six time points (1, 22, 35, 60, 81 and 114 days)
throughout the treatment. Kinematic analysis of the passing
motion was completed using Cortex (Motion Analysis
Corporation, Santa Rosa, CA) and The MotionMonitor
software (Innovative Sports Training, Chicago, IL). Pain
during each kick was rated on a scale from 1 to 10. A one-
way analysis of variance (ANOVA) was used to determine
Fig. 1 a Pre-operative radiograph demonstrating heterotopic ossification in the right hip capsule. b Post-operative radiograph after removal of
the heterotopic ossification
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Fig. 2 Mean peak ground
reaction force of the stance leg
and mean linear foot velocity at
ball strike of the kicking leg of
the six evaluation sessions
throughout treatment. Time
points for PRP/BMAC injection
are displayed on horizontal axis.
A significant increase
(p \ 0.01) in peak GRF and
linear foot velocity at ball strike
was observed between pre-
treatment and 4 months post-
treatment. Error bars represent
1 standard deviation
Fig. 3 a Mean peak hip
abduction of the stance leg.
A significant increase
(p \ 0.05) in peak hip
abduction was observed
between pre-treatment and
4 months post-treatment. Error
bars represent 1 standard
deviation. b Maximum hip
flexion of the kicking leg
following ball strike with 54
reflective markers significantly
increased between pre-treatment
(left) and 4 months post-
treatment (right; p \ 0.05)
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the statistical significance of the improvements (p \ 0.005;
SPSS, IBM Corp, Armonk, NY).
The motion analysis results demonstrated continuous
improvement in kicking performance while his subjective
pain score consistently decreased over the treatment time
period. The mean magnitude of the ground reaction force of
his stance leg demonstrated a significant increase from
1,385 N ± 115 before therapy, to a maximum of 2,115 N ±
141 at treatment day 81 (p \ 0.01, Fig. 2). Additionally, the
mean peak hip abduction angle of his stance leg increased
over the treatment period from 9.3 ± 1.1 to 23.6 ± 1.1
(p \ 0.05, Fig. 3a). Both these results suggest an increase in
confidence and performance of his involved hip to withstand
the high impact load of planting his stance leg during the
cross kick. His kicking performance also improved as the
linear foot velocity of his kicking leg at the time of ball strike
significantly increased from 7.9 m/s ± 0.5 to a maximum of
11.9 m/s ± 1.1 over the same time period (p \ 0.01, Fig. 2).
And finally, maximum hip flexion after ball strike in his
kicking limb significantly increased over the treatment per-
iod (p \ 0.05, Fig. 3b).
Discussion
The most important finding of the present study is that a
professional soccer player with a hip capsular soft tissue
injury experienced improvement in pain, range of motion
and strength in his affected extremity with the combination
use of PRP and BMAC injections. In addition, he dem-
onstrated marked improvement in the kinematic and kinetic
performance measures of a cross soccer pass, and his torn
hip capsule and gluteus minimus tendon on MRI appeared
more morphologically similar to native low-signal tendon
tissue.
It is theorized that the proliferation and differentiation of
the mesenchymal stem cells contained in BMAC into
functional tenocytes and chondrocytes may be augmented
by the growth factors and peptides within PRP and
potentially allow for healing of soft tissue injuries in vivo.
However, there is a paucity of data in the current literature
in regard to the efficacy of these biologics used in com-
bination. The limited data available does suggest that their
effects may potentiate each other [3, 10, 12, 13, 17, 30, 31].
Specifically, Wang et al. reported that treatment of mes-
enchymal stem cells derivatives, tenocytes (human tendon
precursor cells), with activated PRP accelerated cell rep-
lication and collagen production [31]. In a separate study,
PRP was reported to induce a significantly higher expan-
sion rate of mesenchymal stromal cells in vitro compared
to the widely used foetal calf serum [10]. These studies
suggest that the combination of BMAC and PRP may
potentiate the differentiation of mesenchymal stem cells
into functional tenocytes as compared to either biologic
agent used in isolation and may ultimately expedite soft
tissue repair in vivo.
The present report provides an example of the combi-
nation use of PRP and BMAC to heal a hip capsular defect
and gluteus minimus tendon tear in a high-demand athlete.
This case highlights the therapeutic potential that may be
derived from the use of PRP and BMAC in the treatment of
soft tissue injuries of the hip capsule. Although more
studies need to be completed to confirm the therapeutic
benefits of these agents used in combination, it seems they
may offer a plausible alternative to invasive surgical cap-
sule repair in select patients.
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